Bydureon BCise side

Bydureon BCise is a once‑weekly, single‑dose autoinjector of extended‑release exenatide for adults with type 2 diabetes; the recommended dose is 2 mg subcutaneously once weekly, and it carries a boxed warning about thyroid C‑cell tumors and contraindications for patients with a personal or family history of medullary thyroid carcinoma or MEN 2.